Clinical Trial Update: To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder. [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated NMRA-335140 for depressive symptoms in Bipolar II disorder. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Ii Disorder

Drugs mentioned

• NMRA-335140

Snippet

Sponsor: Neumora Therapeutics, Inc. | Conditions: Major Depressive Episode Associated With Bipolar II Disorder | Phase 2 | Status: COMPLETED